Decision Support for BRCA Testing in Ethnically Diverse Women
Completed · Not applicable
Conditions studied: Breast Cancer, BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer
In brief
The objective of this study is to expand genetic testing for hereditary breast and ovarian cancer syndrome to a broader population of high-risk women by prompting appropriate referrals from the primary care setting with the use of an electronic health record-embedded breast cancer risk navigation (BNAV) tool. To address patient-related barriers to genetic testing, the investigators developed a web-based decision aid, RealRisks, which is designed to improve genetic testing knowledge, accuracy of breast cancer risk perceptions, and self-efficacy to engage in a collaborative dialogue about genetic testing. The study design is a randomized controlled trial of patient educational materials and provider electronic health record (EHR) notice alone (control arm) or in combination with RealRisks and BNAV (intervention arm). The investigators hypothesize that combining the patient-centered RealRisks with the provider-centered BNAV will increase appropriate uptake of genetic counseling. The investigators also hypothesize that genetic counseling decisions will be more informed, and result in less decision conflict and improved shared decision making.
Key facts
- Study ID
- NCT03470402
- Run by
- Columbia University
- People needed
- 276
- Starts
- 2017-12-13
- Expected to finish
- 2020-08-17
- Last updated by the study team
- 2021-04-19
Who can join
Age: 21 and older, up to 75. Sex: female. Healthy volunteers: accepted.
Where it is running
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.